StealthCo is a seed-stage techbio company, created within DSV, building a computational drug discovery platform that constructs causal biological networks from large-scale primary human single-cell omics data and structured published experimental literature. Our multi-agent AI system reasons over these networks to generate, simulate, and rank mechanistic hypotheses for combination therapies — with system accuracy verified against top-tier researchers at the Allen Institute. We will initially focus on oncology indications.

The Role (remote, timezone-restricted)

You will design and build production bioinformatics pipelines for new modalities—spatial transcriptomics, single-cell proteomics, and spatial proteomics—extending our existing scRNA-seq infrastructure. These pipelines feed directly into an agentic hypothesis generation system: the quality of what goes in de...